申请人:Sandoz, Inc.
                            
                            
                                公开号:US04175191A1
                            
                            
                                公开(公告)日:1979-11-20
                            
                            3-Substituted-4-aryl isoquinolines, e.g. 3-tertiary butyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline, prepared from corresponding isoquinoline intermediates, are useful as anti-diabetic agents.
                            3-取代-4-芳基
异喹啉,例如3-叔丁基-
4-苯基-1,2,3,4-四氢异喹啉,是从相应的
异喹啉中间体制备而成的,可用作抗糖尿病药物。